,

Elissar Andari1,2,3,4, Kaundinya Gopinath5, Erin O'Leary6,7

  • 1Department of Neurosciences and Psychiatry, College of Medicine and Life Sciences, University of Toledo, Toledo, OH, USA. eandari@gmail.com.

概括

鼻内催产素 (IN-OXT) 在治疗自闭症谱系障碍 (ASD) 和社会缺陷方面表现有前途. 更高的剂量,特别是48 IU,在正常化大脑连接方面更有效,这表明未来ASD治疗的潜力.